FOXP3 and neoplasm: In tumor tissues examined 14 days after the last immunization, no FOXP3+ T cells were identified in the mice treated with the combination therapy, whereas scarce FOXP3+ T cells were found in the corresponding tumors from mice treated with the IFN-DC vaccine alone.